Awards & Accreditations
Fosun Cancer Hospital Guangzhou hospitals in China hold JCI international accreditation, China's highest
hospital rating Grade III-A, and 8 recent international awards & industry recognitions —
the quality behind your care is verified, not promised.
-
-
Oncology ServiceProvider of theYear in Asia-PacificGloba Health AWARDS2026
-
TCM HospitalProvider of theAsia-PacificGloba Health AWARDS2026
-
Hospital ofthe YearChinaGloba Health AWARDS2026
Awards & Accreditations
Fosun Cancer Hospital Guangzhou hospitals in China hold JCI international accreditation, China's highest
hospital rating Grade III-A, and 8 recent international awards & industry recognitions —
the quality behind your care is verified, not promised.
-
-
Oncology ServiceProvider of theYear in Asia-PacificGloba Health AWARDS2026
-
TCM HospitalProvider of theAsia-PacificGloba Health AWARDS2026
-
Hospital ofthe YearChinaGloba Health AWARDS2026
Why Choose Us
-
26,000+Over 26,000 international patient visits from 124 countries and regions. -
1,000+Over 1,000 cancer patients treated with our sixth-generation CyberKnife. -
800+Over 800 patients treated with the da Vinci Surgical System since April 2023. -
500+Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.
Why Choose Us
-
26,000+Over 26,000 international patient visits from 124 countries and regions. -
1,000+Over 1,000 cancer patients treated with our sixth-generation CyberKnife. -
800+Over 800 patients treated with the da Vinci Surgical System since April 2023. -
500+Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.
Cancer Treatment Technologies
Advanced care at greater value. Fosun Cancer Hospital Guangzhou makes world-class cancer treatment more accessible.
Expert Team
More

Yang Jun
Specializes in precision radiotherapy, radiosurgery, and the radiobiology of hypofractionated tumor radiotherapy.Highly proficient in CyberKnife treatment for solid tumors throughout the body and pioneered the SCART technique, offering a new, non-invasive, and highly effective treatment option for patients with large, inoperable tumors.
More Details

Cui Nianji
With 50 years of professional practice, this expert possesses profound theoretical knowledge and research expertise, alongside extensive clinical experience. They have achieved mastery in the diagnosis and radiotherapy planning for nasopharyngeal, lung, esophageal, hepatobiliary/pancreatic, colorectal, and testicular cancers, as well as in specialized treatment techniques and combined radiotherapy approaches (such as radiotherapy with chemotherapy or hyperthermia).
More Details

Wang Enmin
Specializes in CyberKnife treatment for brain tumors (such as acoustic neuromas, meningiomas, pituitary adenomas, and brain metastases) and extracranial tumors (such as lung, liver, and pancreatic cancers, and spinal metastases).Possesses experience in over 22,000 cases of Gamma Knife and CyberKnife treatments.
More Details

Guo Zhuming
Specializes in the surgical treatment of malignant head and neck tumors, including cancers of the thyroid, larynx, tongue, and paranasal sinuses, as well as malignant breast tumors. Emphasizes functional preservation and comprehensive treatment strategies, backed by over thirty years of extensive clinical experience.
More Details

Zhang Dongxing
Specializes in minimally invasive interventional and precision therapies for solid tumors, including lung, esophageal, breast, liver, bile duct, pancreatic, and colorectal cancers; highly proficient in techniques such as vascular intervention, argon-helium cryoablation, and radiofrequency ablation.
More Details

Lv Yue
Expert in the diagnosis and treatment of leukemia, lymphoma, multiple myeloma, MDS, and complex metastatic tumors; possesses profound expertise and extensive clinical experience in the field of hematologic oncology.
More Details

Peng Qirong
Specializes in minimally invasive interventional procedures, seed implantation, ablation, and hyperthermia for malignant tumors such as liver, lung, esophageal, and gastric cancers; possesses extensive experience in the minimally invasive diagnosis and treatment of digestive system tumors.
More Details

Ye Gang
Possesses over 30 years of clinical experience in the US and China; specializes in various cancers and hematological disorders, with profound expertise in the diagnosis and treatment of breast cancer, lung cancer, lymphoma, and multiple myeloma, as well as extensive experience in the clinical application of innovative drugs.
More Details
Expert Team
Read More

Yang Jun
Specializes in precision radiotherapy, radiosurgery, and the radiobiology of hypofractionated tumor radiotherapy.Highly proficient in CyberKnife treatment for solid tumors throughout the body and pioneered the SCART technique, offering a new, non-invasive, and highly effective treatment option for patients with large, inoperable tumors.
More Details

Cui Nianji
With 50 years of professional practice, this expert possesses profound theoretical knowledge and research expertise, alongside extensive clinical experience. They have achieved mastery in the diagnosis and radiotherapy planning for nasopharyngeal, lung, esophageal, hepatobiliary/pancreatic, colorectal, and testicular cancers, as well as in specialized treatment techniques and combined radiotherapy approaches (such as radiotherapy with chemotherapy or hyperthermia).
More Details

Wang Enmin
Specializes in CyberKnife treatment for brain tumors (such as acoustic neuromas, meningiomas, pituitary adenomas, and brain metastases) and extracranial tumors (such as lung, liver, and pancreatic cancers, and spinal metastases).Possesses experience in over 22,000 cases of Gamma Knife and CyberKnife treatments.
More Details

Guo Zhuming
Specializes in the surgical treatment of malignant head and neck tumors, including cancers of the thyroid, larynx, tongue, and paranasal sinuses, as well as malignant breast tumors. Emphasizes functional preservation and comprehensive treatment strategies, backed by over thirty years of extensive clinical experience.
More Details

Zhang Dongxing
Specializes in minimally invasive interventional and precision therapies for solid tumors, including lung, esophageal, breast, liver, bile duct, pancreatic, and colorectal cancers; highly proficient in techniques such as vascular intervention, argon-helium cryoablation, and radiofrequency ablation.
More Details

Lv Yue
Expert in the diagnosis and treatment of leukemia, lymphoma, multiple myeloma, MDS, and complex metastatic tumors; possesses profound expertise and extensive clinical experience in the field of hematologic oncology.
More Details

Peng Qirong
Specializes in minimally invasive interventional procedures, seed implantation, ablation, and hyperthermia for malignant tumors such as liver, lung, esophageal, and gastric cancers; possesses extensive experience in the minimally invasive diagnosis and treatment of digestive system tumors.
More Details

Ye Gang
Possesses over 30 years of clinical experience in the US and China; specializes in various cancers and hematological disorders, with profound expertise in the diagnosis and treatment of breast cancer, lung cancer, lymphoma, and multiple myeloma, as well as extensive experience in the clinical application of innovative drugs.
More Details
Patient Stories
More
-
Stage IIA invasive breast cancerMaya ChinaFosun Cancer Hospital Guangzhou, This Fosun Cancer Hospital Guangzhou patient story follows an Indonesian woman with Stage IIA breast cancer through breast-conserving surgery, chemotherapy, radiotherapy, endocrine therapy, lymphedema rehabilitation, and multidisciplinary recovery support in China. -
Stage I breast cancerAmisha IndonesiaFosun Cancer Hospital Guangzhou, This Fosun Cancer Hospital Guangzhou story follows a 34-year-old Indonesian patient with HER2-positive breast cancer who preserved fertility before chemotherapy, underwent bilateral mastectomy, and continued endocrine therapy during recovery in China.
Patient Stories
-
Stage IIA invasive breast cancerMaya ChinaFosun Cancer Hospital Guangzhou, This Fosun Cancer Hospital Guangzhou patient story follows an Indonesian woman with Stage IIA breast cancer through breast-conserving surgery, chemotherapy, radiotherapy, endocrine therapy, lymphedema rehabilitation, and multidisciplinary recovery support in China. -
Stage I breast cancerAmisha IndonesiaFosun Cancer Hospital Guangzhou, This Fosun Cancer Hospital Guangzhou story follows a 34-year-old Indonesian patient with HER2-positive breast cancer who preserved fertility before chemotherapy, underwent bilateral mastectomy, and continued endocrine therapy during recovery in China. -
Breast cancerSiti IndonesiaFosun Cancer Hospital Guangzhou, This Fosun Cancer Hospital Guangzhou patient story follows a 38-year-old Indonesian woman through breast cancer surgery with reconstruction, chemotherapy, and five-year Tamoxifen therapy, balancing cancer control with recovery and body image.
Patient TestimonialsSay's
More
TESTIMONIALS
Surgery is only the beginning of the journey against cancer; breast cancer is a lifelong battle that must be faced for a lifetime.

Maya
Patient
She expressed gratitude to the medical team for patiently, meticulously, and warmly explaining her condition and treatment plan in Indonesian, helping to relieve her anxiety and unease.

Amisha
Patient
She expressed gratitude to Director Zeng Zhiqiang and his team for their exceptional medical care and emotional support, which enabled her to bravely face breast cancer and rekindle her passion for life. Sharing experiences with fellow patients also helped her find hope and become more positive and optimistic.

Siti
Patient
Patient TestimonialsSay's
TESTIMONIALS
Service Center
More
-
Hospital EnvironmentA high-quality healthcare environment built to international standards, bringing greater comfort and peace of mind throughout treatment.
Patient Guide
We provide thoughtful pre-arrival arrangements and a
clear care pathway, helping you navigate every detail with confidence.
-
Consultation
-
Teleconsult
-
TreatmentPlan
-
TravelPrep
-
AirportPickup
-
Admission
-
Aftercare
-
Follow-Up










